VK-0214

DB17670InvestigationalSmall molecule

VK-0214: Overview.

Chemical structure of VK-0214
Formula / weight
C23H25O5P · 412.422 g/mol (avg)
Also known as
(((4-(3-benzyl-4-hydroxybenzyl)-3,5-dimethylphenyl)oxy)methyl)phosphonic acid · ((4-(3-benzyl-4-hydroxybenzyl)-3,5-dimethylphenoxy)methyl)phosphonic acid · Phosphonic acid, p-((4-((4-hydroxy-3-(phenylmethyl)phenyl)methyl)-3,5-dimethylphenoxy)methyl)-
Code names
VK-0214

Resolves to

Compound
UNII6FGG71NJ3YCAS852949-30-5ChEMBLCHEMBL4802139
Structure
InChIKeyGFJCILQBXUTOGN-UHFFFAOYSA-NSMILESCC1=CC(OCP(O)(O)=O)=CC(C)=C1CC1=CC=C(O)C(CC2=CC=CC=C2)=C1
Targets
P10828THRB

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with VK-0214, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In